Life Science News

Cloud DX Cloud DX, a leading North American provider of virtual care and remote patient monitoring solutions, today reports results for the third quarter of fiscal 2021Key Developments:Overall revenue lower by 4%; Subscription revenue increased 22%New partnerships in the quarter resulted in access to up to 27,000 patientsInclusion of one-time costs attributed to the Qualifying Transaction impacted expenses;120% ...

Cloud DX (TSXV:CDX)(OTCQB:CDXFF), Cloud DX, a leading North American provider of virtual care and remote patient monitoring solutions, today reports results for the third quarter of fiscal 2021

Key Developments:

  • Overall revenue lower by 4%; Subscription revenue increased 22%
  • New partnerships in the quarter resulted in access to up to 27,000 patients
  • Inclusion of one-time costs attributed to the Qualifying Transaction impacted expenses;
    • 120% increase in operating expenses
    • 98% decrease in adjusted EBITDA

Third Quarter Financial Highlights

Year to Date Financial Highlights

Revenue

In the 3 months ended September 30, 2021 subscription revenue was 19% lower. Product and professional services revenue is anticipated to be variable in the early stages of growth. Specifically, in 2020 a large Connected Health Kit deployment for an academic study generated an unusual concentration of hardware revenue that has not occurred in 2021.

In the 9 months ended September 30, 2021 subscription revenue increased 22%. Similar to the three-month period, product and professional services revenue is projected to fluctuate in the early stages of growth. As noted above, in 2020 a large project-based order of Connected Health Kits had no comparison to date in 2021.

Expenses

In the 3 months ended September 30, 2021 operating expenses increased 20% predominantly caused by certain cash and non-cash expenditures associated with the Qualifying Transaction. Salaries and wages were 38% higher thanks to an additional 27 employees between September 30, 2020 and September 30, 2021. Sales, General and Administrative was 223% higher due to higher comparative advertising and promotion, insurance and subscription costs as compared to September 2020.

In the 9 months ended September 30, 2021, operating expenses increased 72% primarily driven by certain cash and non-cash expenditures associated with the RTO; Professional fees were 41% higher caused by costs attributable to this transaction; stock based compensation was higher due to the obligation to revalue employee stock-based compensation granted as previously issued stock options were cancelled prior to the RTO. Headcount increased by 29 FTEs between September 30, 2020 and September 30, 2021 causing a 74% increase in salaries and wages.

Customer Stats

Cloud DX has seen access to available patients suited to its remote patient monitoring products increase as follows:

About Cloud DX

Accelerating virtual healthcare, Cloud DX is on a mission to make healthcare better for everyone. Our Connected Health TM remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable aging in place, and deliver hospital-quality post-surgical care in the home. Our partners achieve better healthcare and patient outcomes, reduce the need for hospitalization or re-admission, and reduce healthcare delivery costs through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist, and one of "Canada's Ten Most Prominent Telehealth Providers.

Cloud DX Investor Site https://ir.clouddx.com/overview/default.aspx

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Social Links
Twitter https://twitter.com/CloudDX
Facebook https://www.facebook.com/clouddxinc/
LinkedIn https://www.linkedin.com/company/cloud-dx/
Instagram https://www.instagram.com/cloud.dx/

For investor inquiries please contact:
Jay Bedard
Cloud DX Investor Relations
647-881-8418
jay.bedard@CloudDX.com

SOURCE: Cloud DX Inc.



View source version on accesswire.com:
https://www.accesswire.com/675180/Cloud-DX-Reports-Fiscal-Third-Quarter-Results

News Provided by ACCESSWIRE via QuoteMedia

Cloud DX

Cloud DX

Overview

The COVID-19 global pandemic shook traditional healthcare structures on a global scale in 2020. There has been an urgent need for integrated systems to manage the influx of patients and new social distancing measures, which forced many to delay seeking in-person medical attention. In identifying this gap in the healthcare system, digitally driven telemedicine companies are leading the way to innovate and improve healthcare for all in this increasingly digital age.

By 2022, the global healthcare market is forecasted to grow to US$11.9 trillion, with the digital healthcare sector to grow by a projected compound annual growth rate (CAGR) of 38 percent by 2026. In dealing with the aftermath of this pandemic, investing in healthcare and wellness technology is investing in the healthcare systems we’ve needed for a long time.

Keep reading... Show less
KWESST Announces Branding of Non-Lethal Low Energy Cartridge  System in Conjunction with Launch at SHOT Show 2022 - Booth # 40022

KWESST Announces Branding of Non-Lethal Low Energy Cartridge System in Conjunction with Launch at SHOT Show 2022 - Booth # 40022

KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) ("KWESST" or the "Company") today announced that it will be launching its non-lethal Low Energy Cartridge (LEC) product line under the brand PARA OPS in conjunction with the opening of the 2022 SHOT Show in Las Vegas January 18-21. The PARA OPS website which can be found at www.para-ops.com and it will go live the on January 17, the day before the SHOT Show. You can visit KWESST at the SHOT Show at booth #40022.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/7366/110116_4f007e92e4f9aafd_002full.jpg

Keep reading... Show less
Cloud DX Inc. Announces Update to Brokered Private Placement

Cloud DX Inc. Announces Update to Brokered Private Placement

Cloud DX Inc. ("Cloud DX" or the "Company") (TSXV:CDX) announces that it has updated the terms of its private placement previously announced on January 4, 2022 of Convertible Debenture Units (the "Updated Offering") with Echelon Wealth Partners Inc. as lead agent and sole book runner (the "Agent"). The Company expects the initial closing of the Updated Offering will be on or about January 25, 2022

In connection with the Updated Offering the Agent will offer for sale up to 3,000 convertible debenture units of the Company (the "Convertible Debenture Units") at a price of $1,000 per Convertible Debenture Unit for aggregate gross proceeds of up to $3,000,000. The Agent has been granted an option to sell up to 450 additional Convertible Debenture Units for maximum aggregate gross proceeds under the Updated Offering of $3,450,000. Pursuant to the Updated Offering, each Convertible Debenture Unit will be comprised of $1,000 principal amount unsecured convertible debenture (each, a "Debenture") and 1,430 common share purchase warrants of the Company (each, a "Warrant"). The Debentures will mature on the date that is 36 months from the date of issuance (the "Maturity Date") and shall bear interest at a simple rate of 10% per annum. Interest will be payable quarterly on the last business day of each quarter, commencing on March 31, 2022. The principal amount of the Debentures, or any portion thereof, may be converted at the election of the holder thereof into common shares in the capital of the Company ("Common Shares") at a conversion price of $0.35 per Common Share (the "Conversion Price") at any time prior to the Maturity Date. Each Warrant will entitle the holder thereof to acquire one Common Share at a price of $0.50 per Common Share for a period of 24 months from the closing date of the Updated Offering.

Keep reading... Show less
Cloud DX Receives Partnership Funding for Clinical Research of Next Generation Wrist-Worn Vital-Sign Monitoring Device

Cloud DX Receives Partnership Funding for Clinical Research of Next Generation Wrist-Worn Vital-Sign Monitoring Device

The New Brunswick Health Research Foundation (NBHRF) partners with Cloud DX to fund Calibration and Validation research of its patented Pulsewave 2.0, a Non-Invasive Vital Sign Monitoring Device

News in Summary

Keep reading... Show less
Nanalysis Announces the Closing of Acquisition of K' Technologies Inc.

Nanalysis Announces the Closing of Acquisition of K' Technologies Inc.

Nanalysis Scientific Corp. ( TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") is pleased to announce that it has successfully closed the previously announced acquisition of K'(Prime) Technologies Inc. (KPrime), a North American sales and service company, with a particular focus on scientific instrumentation for pharma, food, chemical and oil & gas customers, as well as imaging systems for security applications.

Keep reading... Show less
Cloud DX Announces Contracts with US Primary Care Clinics

Cloud DX Announces Contracts with US Primary Care Clinics

Cloud DX and partner Maxwell Telecare sign three new clinics for Remote Patient Monitoring (RPM) deployment, expanding on its Maxwell partnership

News in Summary

Keep reading... Show less
KWESST Announces $400,000 in Police Orders for ARWEN Products

KWESST Announces $400,000 in Police Orders for ARWEN Products

KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) ("KWESST" or the "Company") is pleased to announce that it has received orders from three law enforcement agencies for approximately $400,000 in ARWEN products (all values in CAD). One order from an overseas national police agency is for approximately $250,000 to be shipped next month. The other two orders are from Canadian law enforcement agencies, with one order shipped in late December 2021 and the other scheduled to ship this month.

"It is gratifying to see this early acceleration in the pace of orders from our recent acquisition of ARWEN," said Jeff MacLeod, Founder, President and CEO of KWESST. "This reinforces our conviction that there is strong growth potential for ARWEN products around the world, particularly in an environment of heightened civil unrest and anxiety about rising crime."

Keep reading... Show less

Latest Press Releases

Related News

×